Neuron-specific enolase, S-100 protein, myelin basic protein and lactate in CSF in Dementia

Dementia and Geriatric Cognitive Disorders

Volumn 8, Issue 3, 1997, Pages 169-173

  Nooijen, P T G A ^a   Schoonderwaldt, H C ^a   Wevers, R A ^a   Hommes, O R ^a   Lamers, K J B ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

CSF; Lactate; Myelin basic protein; Neuron specific enolase; S 100

Indexed keywords

LACTIC ACID; MYELIN BASIC PROTEIN; NEURON SPECIFIC ENOLASE; PROTEIN S 100;

AGED; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DEMENTIA; DIFFERENTIAL DIAGNOSIS; HUMAN; MAJOR CLINICAL STUDY; NORMOTENSIVE HYDROCEPHALUS; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

AGED; CEREBROSPINAL FLUID; DEMENTIA; FEMALE; HUMANS; LACTIC ACID; MALE; MIDDLE AGED; MYELIN BASIC PROTEINS; NEURONS; PHOSPHOPYRUVATE HYDRATASE; S100 PROTEINS;

EID: 0030942966     PISSN: 14208008     EISSN: 14219824     Source Type: Journal    
DOI: 10.1159/000106627     Document Type: Article

References (29)

1. Massaro AR. Scivoletto G, Tonali P: Cerebrospinal fluid markers in neurological disorders. Ital J Neurol Sci 1990;11:537-547.
2. Marangos PJ. Schmechel DE: Neuron-specific enolase, a clinical useful marker for neurons and neuroendocrine cells. Annu Neurosci 1987;10:269-295.
3. Sindic CJM. Chalon MP, Cambiaso CL. La-terre EC, Masson PL: Assessment of damage to the central nervous system by determination of S-100 protein in the cerebrospinal fluid. J Neurol Neurosurg Psychiatry 1982;45:1130-1135.
4. Sternberger NH. Jtoyanta Y, Kies MW, Webster F: Myelin basic protein demonstrated immunocytochemically in Oligodendroglia prior to myelin sheath formation. Proc Natl Acad Sci USA 1978;75:2521-2524.
5. Lamers KJB, van Engelen BGM, Gabreëls FJM. Hommtes OR, Borni GF, Wevers RA: Cerebrospinal neuron-specific enolase, S-100 and myelin basic protein in neurological disorders. Acta Neurol Scand 1995;92:247-251.
6. Persson L. Hardemark MG, Guslafsson J, et al: S-100 protein and neuron-specific enolase in cerebrospinal fluid and scrum markers of cell damage in human central nervous system. Stroke 1987; 18:911-918.
7. Wakayama Y, Shibuya S, Kawase J. Sagawa F, Hashizume Y: High neuron-specific enolase level of cerebrospinal fluid in the early stage of Creutzfeldt-Jacob disease. Klin Wochenschr 1987;65:798-801.
8. Mokuno K, Kato K, Kawai K. Matsuoka Y. Yanagi T, Sobue I: Neuron-specific enolase and S-100 protein levels in cerebrospinal fluid of patients with various neurological diseases. J Neurol Sci 1983:60:443-451.
9. Cutler NR, Kay AD, Marangos PJ. Burg C: Cerebrospinal fluid neuron-specific enolase is reduced in Alzheimer's disease. Arch Neurol 1986:46:153-154.
10. Noppe M. Crols R, Andries D. Lowenthal A: Determination in human cerebrospinal fluid of glial fibrillary- acidic protein, S-100 and myelin basic protein as indices of non-specific or specific control nerous tissue pathology. Clin ChimActa 1986;155:143-150.
11. American Psychiatric Association; Diagnostic and Statistical Manual of Mental Disorders (DSM III-R). Bethesda, American Psychiatric Association. 1987.
12. Schoonderwaldt HC: Normal pressure hydrocephalus. The Doppler-LP test and other selection criteria for shunting; thesis. Nijmegen. 1986.
13. Malm J, Kristensen B, Ekstedt J, Adolfsson R, Wester P; CSF monoamine metabolites, cholinesterasc and lactate in the adult hydrocephalus syndrome (normal pressure hydrocephalus) related to CSF hydrodynamic parameters. J Neurol Neurosurg Psychiatry 1991: 54,3:252-259.
14. Roman GC. Tatemichi TK. Erkinjuntti T, Cummings JL. Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM. Brun A. Hofman A: Vascular dementia: Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-260.
15. Erkinjuntti T: Differential diagnosis between Alzheimer's disease and vascular dementia: Evaluation of common clinical methods. Acta Neurol Scand 1987;76:433-442.
16. Amaducci L. Sorbi S, Piacentini S. Bick KL: The first Alzheimer disease case: A mctachro-matic leukodystrophy? Dev Ncurosci 1991:13: 186-187.
17. Anonymous: Consensustekst diagnostick bij het dementiesyndroom. Utrecht: 4 november 1988.
18. van Engelen BGM. Lamers KJB. Gabreels FJM. Wevers RA, van Geel WJA, Borm GF: Age related changes of neuron-specific enolase. S-100 protein and myelin basic protein concentrations in the cerebrospinal fluid. Clin Chem 1992:38.6:813-816.
19. Lamers KJB. Schoonderwaldt HC. Borkent MV, Theeuwes AGM. Doesburg WH. Wevers RA: The effects of acute cerebrovascular disease on serum and cerebrospinal fluid parameters. Clin Neurol Neurosurg 1987:89:23-27.
20. Dean AD, Dean JA. Burton JH. Dicker RC: Epi-Info. version 5.01b: A Wordprocessing. Database and Statistics Program for Epidemiology on Microcomputers. Atlanta. Centers for Disease Control. 1990.
21. Zerr J, Bodemer M. Räcker S, Grosche S. Poser S. Kretzschmar HA. Weber T: Cerebrospinal fluid concentration of neuron-specific enolase in diagnose of Creutzfeldt-Jacob disease. Lancet 1995;345:1609-1610.
22. Royds JA. Davies-Jones GAB, Lewtas NA. Timperley WR. Taylor CB: Enolase isoenzymes in cerebrospinal fluid of patients with diseases of the nervous system. J Neurol Neurosurg Psychiatry 1983:46:1031-1036.
23. Blennow K, Wallin A, Ekman R: Neuron specific enolase in cerebrospinal fluid: A biochemical marker for neuronal degeneration in dementia disorders. J Neural Transnt 1994:8: 183-191.
24. Vermuyten K. Cowenthal A. Kavcher D: Detection of NSE concentrations in CSF from patients with neurological disorders by means of a sensitive enzyme immunoassay. Clin Chini Acta 1990:187:69-78.
25. Sulkava R. Vicnikka L. Erkinjientti T. Roine R: Cerebrospinal fluid neuron-specific enolase is decreased in multi-infarct dementia but unchanged in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1988:51:549-561.
26. Van den Doel EMIL Rijksen G. Staal GEY: Intérêt et limites de l'étude de la gamma-éno-lase dans le liquide céphalo-rachidien comme lemoin de la dégradation neuronaie Rev Neurol (Paris) 1988:144:452-455.
27. Pametti L. Palumbo B, Cardinali L. Loreti F. Chionne F. Cocotti R. Senin U: Cerebrospinal fluid neuron-specific enolase in Alzheimer's disease and vascular dementia. Neurosci Lett 1995:183(1-2):43-45.
28. Van Gool WA. Bolhuis PA: Studies of cerebrospinal fluid diagnosis in Alzheimer's disease: A review of the literature and of current developments. Tijdschr Gerontol Geriatr 1992:23.6: 212-216.
29. Thompson EJ. Keir G: Laboratory investigation of cerebrospinal fluid protein. Ann Clin Biochem 1990:27:425-435.